{
  "id": 11163301,
  "title": "A Cancer Test Has Investors Betting Big. But Will Insurers Pay?",
  "url": "https://urgent.news/2026/10/01/a-cancer-test-has-investors-betting-big-but-will-insurers-pay",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T09:30:00.000Z",
  "source": {
    "name": "WSJ Markets",
    "slug": "wsj-markets",
    "url": "https://www.wsj.com/health/healthcare/a-cancer-test-has-investors-betting-big-but-will-insurers-pay-75d3bc60?mod=rss_markets_main"
  },
  "original_language": "en",
  "account": null,
  "summary": "An FDA panel backed Grail’s Galleri test. But the Medicare money the business depends on is far from guaranteed.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}